Bulk RNA-seq analysis of liver biopsy specimens from patients with MASLD demonstrated that hepatic ACSL3 expression increased stepwise with higher NAS, indicating a positive association with histological severity (Figure 5A). The gene discussed is ACSL3; the disease is metabolic dysfunction-associated steatotic liver disease.